ARCHIVES

NCAB Decides To End IGs, Review total Research Support, And Consider P01 Limitation

This article is from The Cancer Letter archive.

Vol. 18 No. 24 | June 12, 1992

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Would Give Clearer Picture Of C225 Role.

February 15, 2002

NTP Board Okays Contract Concepts

July 10, 1981

Seattle Institutions Win $16 Million In Grants For Comparative Effectiveness Research

October 16, 2009

Death On Saltz Regimen Prompt Groups To Suspend Accrual On Colon Cancer Trials.

May 11, 2001

ODAC Calls For Tougher Standards For Accelerated Approval In Oncology

February 11, 2011

NCI Leaders, Others Defend Cancer Program Against Bailar’s Charge They Are Losing War Against Cancer

May 16, 1986